577-578DOI: 10.17235/reed.2020.6737/2019
11/07/2020 19:32:26 comentar : 1.- Se consideró como brote de C.U, sin tener evidencia endoscópica del mismo, previo a trat con Corticoides 2.- Hablan de brote, pero no se aportan si en la pieza se objetivaron datos de actividad inflamatoria en el resto del colon. 3.- Se realizó estudio de CMV con IHQ+/- PCR?. 4.- La perforación podría estar en relación con el tratamiento esteroideo
Original
Psychological disorders and coping strategies in patients with inflammatory bowel disease. Their impact on health-related quality of life
DOI: 10.17235/reed.2023.9935/2023
Letter
Primary rectal mucosa-associated lymphoid tissue lymphoma masquerading as proctitis
DOI: 10.17235/reed.2023.9872/2023
Sarcopenia and treatment failure in inflammatory bowel disease: a systematic review and meta-analysis
DOI: 10.17235/reed.2023.9808/2023
Giant sigmoid diverticulum
DOI: 10.17235/reed.2023.9804/2023
1-L polyethylene glycol + ascorbic acid versus sodium picosulfate + magnesium citrate bowel preparations for colonoscopy: effectiveness and safety
DOI: 10.17235/reed.2023.9785/2023
Dried lemon slices improve bowel cleansing quality of polyethylene glycol for colonoscopy preparation: randomized controlled trial
DOI: 10.17235/reed.2023.9676/2023
A slightly different polyp: melanoma metastasis diagnosed by colonoscopy
DOI: 10.17235/reed.2023.9667/2023
Idiopathic mesenteric phlebosclerotic colitis associated with Chinese herbal medicine
DOI: 10.17235/reed.2023.9641/2023
MALT lymphoma of the colon: an endoscopic challenge
DOI: 10.17235/reed.2023.9595/2023
Diagnosis of non-Hodgkin's lymphoma due to a tiny polyp in the cecum
DOI: 10.17235/reed.2023.9543/2023
Long-term clinical outcomes after the discontinuation of anti-TNF agents in patients with inflammatory bowel disease: a meta-analysis
DOI: 10.17235/reed.2023.9537/2023
Fecal immunochemical test for hemoglobin versus fecal calprotectin to monitor endoscopic activity in inflammatory bowel disease
DOI: 10.17235/reed.2023.9536/2023
Severe outbreak of ulcerative colitis and cerebral neoplasia. Difficult management in COVID time
DOI: 10.17235/reed.2023.9527/2023
A rare case of an esophageal neuroendocrine carcinoma arising on an endoscopic resection scar
DOI: 10.17235/reed.2023.9523/2023
Editorial
Transmural or mucosal healing in Crohn´s disease. Which is the goal to be pursued?
DOI: 10.17235/reed.2023.9492/2023
The HLA-DQA1*05 genotype does not influence the clinical response to ustekinumab and vedolizumab
DOI: 10.17235/reed.2023.9491/2023
Sigmoid volvulus management, only endoscopic devolvulation?
DOI: 10.17235/reed.2023.9488/2023
Foreign body impaction between diverticula: an uncommon cause of chronic abdominal pain
DOI: 10.17235/reed.2023.9485/2023
Hepatosplenic T-cell lymphoma and inflammatory bowel disease
DOI: 10.17235/reed.2023.9472/2023
Relevance of patient-reported outcome measures (PROM) and patient-reported experience measures (PREM) to assess disease status and quality of care in patients with inflammatory bowel disease
DOI: 10.17235/reed.2023.9563/2022
Colonic perineurioma of the transverse colon: presentation of a rare neoplasm in an atypical location
DOI: 10.17235/reed.2023.9440/2022
Reply: SARS-CoV-2 vaccination in inflammatory bowel disease patients with different biological agents
DOI: 10.17235/reed.2023.9438/2022
Henoch-Schönlein purpura masquerading as Crohn’s disease flare
DOI: 10.17235/reed.2022.9414/2022
SARS-CoV-2 vaccination in inflammatory bowel disease patients with different biological agents: correspondence
DOI: 10.17235/reed.2023.9347/2022
Prediagnosis of soft tissue infection that was finally diagnosed as pyoderma gangrenosum of ulcerative colitis
DOI: 10.17235/reed.2022.9332/2022
Digestive Diseases Image
Complicated giant colonic diverticulum: imaging-based diagnosis
DOI: 10.17235/reed.2022.9312/2022
Factors of easy and difficult cecal intubation during unsedated colonoscopy
DOI: 10.17235/reed.2023.9283/2022
Colon adenocarcinoma associated with intestinal sarcoidosis
DOI: 10.17235/reed.2022.9279/2022
Impact of SARS-CoV-2 vaccination in inflammatory bowel disease patients with different biological agents: a systematic review and meta-analysis
DOI: 10.17235/reed.2022.9264/2022
Colon necrosis in acute severe pancreatitis
DOI: 10.17235/reed.2022.9263/2022
A case of an inverted appendiceal stump with dysplastic mucosa mimicking cecal polyp managed by a combined endoscopic laparoscopic approach
DOI: 10.17235/reed.2022.9237/2022
Colonic malignancy: always adenocarcinomas?
DOI: 10.17235/reed.2022.9223/2022
A rare case of ulcerative colitis following Bacillus Calmette-Guérin therapy
DOI: 10.17235/reed.2022.9191/2022
Splenic rupture after colonoscopy for colorectal cancer screening
DOI: 10.17235/reed.2022.9177/2022
An uncommon colonic polyp
DOI: 10.17235/reed.2022.9160/2022
Crohn’s disease induced by ocrelizumab in a patient with multiple sclerosis
DOI: 10.17235/reed.2022.9152/2022
Serologic response to COVID-19 vaccines in patients with inflammatory bowel disease: a prospective study
DOI: 10.17235/reed.2022.9101/2022
The sentinel polyp: high-grade sarcoma revealed after colonic polypectomy
DOI: 10.17235/reed.2022.9093/2022
Intestinal obstruction due to bariolith impaction
DOI: 10.17235/reed.2022.9084/2022
Cat scratch lesions as a manifestation of chronic colitis due to spirochetosis
DOI: 10.17235/reed.2022.9078/2022
Anorectal malignant melanoma, a diagnostic challenge
DOI: 10.17235/reed.2022.9068/2022
Lead ingestion, medical emergency and action plan
DOI: 10.17235/reed.2022.9048/2022
Giant ascending colonic lipoma accompanied by intussusception
DOI: 10.17235/reed.2022.9041/2022
Endoscopic findings of radiation ileitis
DOI: 10.17235/reed.2022.9036/2022
Review
“Out of the box” new therapeutic strategies for Crohn´s disease: moving beyond biologics
DOI: 10.17235/reed.2022.9010/2022
The neutrophil-lymphocyte ratio as a predictor of steroid response in patients with severe ulcerative colitis: a retrospective cohort study
DOI: 10.17235/reed.2022.9006/2022
Pneumatosis intestinalis: a rare endoscopic feature of colonic ischemia
DOI: 10.17235/reed.2022.8980/2022
Endoscopic imaging of pneumatosis intestinalis
DOI: 10.17235/reed.2022.8972/2022
Inflammatory myofibroblastic tumor presenting as a subepithelial lesion of the colon
DOI: 10.17235/reed.2022.8968/2022
Underwater versus conventional endoscopic mucosal resection for sessile colorectal polyps: an updated systematic review and meta-analysis
DOI: 10.17235/reed.2022.8956/2022
Colonoscopy — When quality matters
DOI: 10.17235/reed.2022.8942/2022
Endoscopic resolution of intestinal obstruction secondary to colonic gallstone ileus and radicular stenosis of the sigma
DOI: 10.17235/reed.2022.8905/2022
Is urgent colonoscopy without bowel preparation really useful? Colonoscopy without bowel preparation
DOI: 10.17235/reed.2022.8850/2022
Extramedullary plasmacytoma with colonic involvement: experience in a tertiary hospital
DOI: 10.17235/reed.2022.8828/2022
Efficacy and safety of fecal microbiota transplant for recurrent Clostridium difficile infection in inflammatory bowel disease: a systematic review and meta-analysis
DOI: 10.17235/reed.2022.8814/2022
Implementation and impact of an antibiotic control program and multidrug-resistant bacterial colonization in a liver transplant unit
DOI: 10.17235/reed.2022.8810/2022
One appendix too many: a severe IBD-U case in remission after appendectomy
DOI: 10.17235/reed.2022.8809/2022
Experience in the treatment of obstructive colorectal cancer with self-expandable colon prosthesis in a tertiary hospital
DOI: 10.17235/reed.2022.8797/2022
Impact of proactive therapeutic drug monitoring of infliximab during the induction phase in IBD patients. A Bayesian approach
DOI: 10.17235/reed.2022.8781/2022
Diagnosis of metastatic angiosarcoma of the aorta in colonic lesion biopsies
DOI: 10.17235/reed.2022.8780/2022
Combined aortic mural thrombi and limb ischemia in inflammatory bowel disease – A rare vascular manifestation
DOI: 10.17235/reed.2022.8774/2022
A rare case of monomorphic epitheliotropic intestinal T-cell lymphoma mimicking Crohn’s disease
DOI: 10.17235/reed.2022.8757/2022
Colonic Kaposi’s sarcoma as the first clinical manifestation of undiagnosed HIV
DOI: 10.17235/reed.2022.8717/2022
Cytomegalovirus colitis seems to be colon cancer. HIV debut
DOI: 10.17235/reed.2022.8699/2022
Sigmoid colon Schwannoma simulating colon cancer
DOI: 10.17235/reed.2022.8684/2022
Health-related quality of life decline in clinically stable inflammatory bowel disease patients during the COVID-19 outbreak
DOI: 10.17235/reed.2022.8668/2022
Gastrointestinal lymphoma, a rare endoscopic lesion
DOI: 10.17235/reed.2022.8555/2021
ST-elevation myocardial infarction (STEMI) secondary to splenic rupture after colonoscopy
DOI: 10.17235/reed.2022.8541/2021
Cecal MALT lymphoma: a challenging diagnosis
DOI: 10.17235/reed.2021.8526/2021
Misplacement of the PEG tube through the transverse colon, an uncommon but possible complication
DOI: 10.17235/reed.2022.8501/2021
Findings in the distal and proximal colon in colonoscopy screening after positive FIT and related pre-procedure factors
DOI: 10.17235/reed.2022.8409/2021
Inflammatory bowel disease new-onset during secukinumab therapy: real-world data from a tertiary center
DOI: 10.17235/reed.2021.8397/2021
Colonic vasculitis in a woman with end-stage kidney disease and HIV infection
DOI: 10.17235/reed.2021.8363/2021
Anal neoplasia and perianal Crohn’s disease: myth or reality?
DOI: 10.17235/reed.2021.8317/2021
Apoptotic colopathy as a manifestation of Good’s syndrome
DOI: 10.17235/reed.2021.8297/2021
Abdominal ultrasound and its significant role in colon cancer. The advantage of its dynamic nature: using respiratory movements to assess neoplasia relations to adjacent organs
DOI: 10.17235/reed.2021.8252/2021
EBV-positive mucocutaneous ulcer — Only in immunosuppressed patients?
DOI: 10.17235/reed.2021.8245/2021
Radon exposure and inflammatory bowel disease in a radon prone area
DOI: 10.17235/reed.2021.8239/2021
Comparison of satisfaction degree of patients treated at the Inflammatory Bowel Disease Unit (IBDU) of Hospital Universitario 12 de Octubre between previous face-to-face care and telephone care during the COVID-19 pandemic
DOI: 10.17235/reed.2021.8185/2021
Surprises in cecal intubation: foreign bodies in the colon
DOI: 10.17235/reed.2021.8155/2021
Participation in clinical trials increases the detection of pre-malignant lesions during colonoscopy
DOI: 10.17235/reed.2021.8104/2021
EBVMCU in a liver-transplant patient
DOI: 10.17235/reed.2021.8064/2021
Primary or idiopathic intestinal pneumatosis: a rare casual endoscopic finding
DOI: 10.17235/reed.2021.8049/2021
Incidence of inflammatory bowel disease and phenotype at diagnosis in 2011: results of the Epi-IBD 2011 study in the Vigo area
DOI: 10.17235/reed.2021.8003/2021
ABP 501 (adalimumab-atto) in the treatment of inflammatory bowel disease: an example of evidence-based extrapolation
DOI: 10.17235/reed.2021.7921/2021
Impact of Epstein-Barr virus infection on inflammatory bowel disease (IBD) clinical outcomes
DOI: 10.17235/reed.2021.7915/2021
The COVID-19 pandemic shows us in which way the care of patients with inflammatory bowel disease should move
DOI: 10.17235/reed.2021.7765/2020
Hemoperitoneum due to splenic injury after colonoscopy—Perhaps not a so uncommon a complication
DOI: 10.17235/reed.2021.7756/2020
Use of the Boston Bowel Preparation Scale in the real life setting: what affects it?
DOI: 10.17235/reed.2020.7678/2020
Biosimilar infliximab CPT-13 for inflammatory bowel disease in a real clinical setting: pharmacokinetic outcomes, immunogenicity, and drug survival
DOI: 10.17235/reed.2021.7638/2020
Adherence to intravenous biological treatment in inflammatory bowel disease patients during the COVID-19 pandemic
DOI: 10.17235/reed.2020.7562/2020
Consequences and management of COVID-19 on the care activity of an Inflammatory Bowel Disease Unit
DOI: 10.17235/reed.2020.7543/2020
A case of severe diverticulosis in a patient with ulcerative colitis
DOI: 10.17235/reed.2020.7529/2020
The use of contrast-enhanced ultrasound for chronic inflammatory bowel disease
DOI: 10.17235/reed.2020.7499/2020
Views of patients with inflammatory bowel disease during the COVID-19 pandemic: ACCU survey results
DOI: 10.17235/reed.2020.7472/2020
Intestinal obstruction secondary to Crohn-like disease in common variable immu-nodeficiency
DOI: 10.17235/reed.2020.7440/2020
Prevalence of pyoderma gangrenosum and Sweet´s syndrome in inflammatory bowel disease at a tertiary healthcare center
DOI: 10.17235/reed.2020.7431/2020
Evaluation of epicardial adipose tissue and carotid intima-media thickness as a marker of atherosclerosis in patients with inflammatory bowel disease
DOI: 10.17235/reed.2020.7394/2020
Autoimmune hepatitis, primary sclerosing cholangitis, and inflammatory bowel disease. Sequential overlap syndrome: a twist to the mosaic of autoimmunity
DOI: 10.17235/reed.2020.7512/2020
Evaluation of endoscopy requests in the resumption of activity during the SARS-CoV-2 pandemic: denial of nonindicated requests and prioritization of accepted requests
DOI: 10.17235/reed.2020.7375/2020
Inflammatory bowel disease and solid organ transplantation
DOI: 10.17235/reed.2020.7361/2020
Phlebosclerotic colitis: an unusual cause of abdominal pain and hematochezia
DOI: 10.17235/reed.2020.7358/2020
Safety of propofol sedation administered by an endoscopy team for outpatient colonoscopy
DOI: 10.17235/reed.2020.7346/2020
Ustekinumab in Crohn's disease: real-world outcomes and predictors of response
DOI: 10.17235/reed.2020.7352/2020
Splenic rupture as an endoscopic complication: as rare as it appears?
DOI: 10.17235/reed.2020.7342/2020
Severe colon ischemia in patients with severe coronavirus-19 (COVID-19)
DOI: 10.17235/reed.2020.7329/2020
COVID-19. Immunothrombosis and the gastrointestinal tract
DOI: 10.17235/reed.2020.7292/2020
Epstein-Barr virus-positive mucocutaneous ulcer mimicking sigmoid colon adenocarcinoma
DOI: 10.17235/reed.2020.7272/2020
Effectiveness and safety of switching to adalimumab biosimilar ABP 501 in Crohn’s disease: the extrapolation concept
DOI: 10.17235/reed.2020.7253/2020
Ustekinumab treatment for toxic megacolon in severe colonic Crohn’s disease
DOI: 10.17235/reed.2020.7228/2020
Pan-enteric capsule for bleeding high-risk patients. Can we limit endoscopies?
DOI: 10.17235/reed.2020.7196/2020
Fecal microbiota transplantation in the intestinal decolonization of carbapenamase-producing enterobacteriaceae
DOI: 10.17235/reed.2020.7150/2020
COVID-19 and the digestive system: protection and management during the SARS-CoV-2 pandemic
DOI: 10.17235/reed.2020.7128/2020
Efficacy, tolerability and safety of a split-dose bowel cleansing regimen of magnesium citrate with sodium picosulfate – a phase IV clinical observational study
DOI: 10.17235/reed.2020.7073/2020
Intestinal intussusception in an adult diagnosed by colonoscopy, an uncommon way to discover this entity
DOI: 10.17235/reed.2020.7064/2020
Vitamin D and inflammatory bowel disease: what do we know so far?
DOI: 10.17235/reed.2020.7061/2020
Follicular non-Hodgkin lymphoma with primary colonic involvement
DOI: 10.17235/reed.2020.6986/2020
Autoimmune sequential overlap syndrome (autoimmune hepatitis/primary sclerosing cholangitis) and inflammatory bowel disease: three clinical cases
DOI: 10.17235/reed.2020.6938/2020
Gastrointestinal tuberculosis, the great simulator. From inflammatory disease to a tumor
DOI: 10.17235/reed.2020.6934/2020
Closure of colonic deep mural injury and perforation with endoclips
DOI: 10.17235/reed.2020.6880/2020
Usefulness of population pharmacokinetics to optimize the dosage regimen of infliximab in inflammatory bowel disease patients
DOI: 10.17235/reed.2020.6857/2020
Comparison of original and biosimilar infliximab (CTP-13) in biologic-naïve patients with Crohn’s disease and ulcerative colitis: a retrospective, multicenter real-life study in Spain
DOI: 10.17235/reed.2020.6847/2019
Digestive involvement in a patient with Lambert-Eaton syndrome
DOI: 10.17235/reed.2020.6846/2019
Colonic adenocarcinoma arising from traditional serrated adenoma
DOI: 10.17235/reed.2020.6818/2019
Vedolizumab-associated psoriasis: until where does gut selectivity go?
DOI: 10.17235/reed.2020.6817/2019
Is the degree of i2a recurrence in Crohn’s disease secondary to ischemic phenomena?
DOI: 10.17235/reed.2020.6790/2019
Sentinel lymph node mapping for metastasis detection in colorectal cancer: a systematic review and meta-analysis
DOI: 10.17235/reed.2020.6767/2019
Endoscopic submucosal dissection of colonic anisakiasis
DOI: 10.17235/reed.2020.6748/2019
Is celiac disease really associated with inflammatory bowel disease?
DOI: 10.17235/reed.2019.6779/2019
Prognostic significance of lymph node count in high-risk node-negative colon carcinoma
DOI: 10.17235/reed.2020.6709/2019
Effectiveness and safety of adalimumab biosimilar ABP 501 in Crohn’s disease: an observational study
DOI: 10.17235/reed.2020.6693/2019
Association between autoimmune pancreatitis and ulcerative colitis: a report of 12 patients
DOI: 10.17235/reed.2020.6677/2019
Megacolon with infectious etiology that is infrequent in our country: Chagas disease
DOI: 10.17235/reed.2020.6643/2019
Quality of care through the eyes of the patient in a Spanish inflammatory bowel disease unit
DOI: 10.17235/reed.2020.6620/2019
Usefulness of therapeutic drug monitoring of infliximab during the induction period in patients with inflammatory bowel disease
DOI: 10.17235/reed.2020.6618/2019
Diet as an environmental trigger in inflammatory bowel disease: a retrospective comparative study in two European cohorts
DOI: 10.17235/reed.2020.6552/2019
Factors associated with the presence of abnormal levels of fecal calprotectin in patients with negative panenteric studies
DOI: 10.17235/reed.2020.6508/2019
Case Report
Primary colon mantle lymphoma: a misleading macroscopic appearance!
DOI: 10.17235/reed.2019.6405/2019
Megacolon in inflammatory bowel disease: response to infliximab
DOI: 10.17235/reed.2020.6394/2019
Status of transition care in inflammatory bowel disease in Spain. Different medical perspectives
DOI: 10.17235/reed.2019.6310/2019
Randomized clinical trial evaluating the effect of a visual educational leaflet on the preparation of colonoscopies in hospitalized patients
DOI: 10.17235/reed.2019.6317/2019
Diverticulitis in immunodeficient patients: our experience in the management of high-risk patients
DOI: 10.17235/reed.2019.6281/2019
Miniprobe endoscopic ultrasonography for the diagnosis of colon hemangiolymphangioma
DOI: 10.17235/reed.2019.6144/2018
Diet in the etiology of inflammatory bowel disease
DOI: 10.17235/reed.2018.6119/2018
The quality of colonoscopy preparation in a private clinical practice setting
DOI: 10.17235/reed.2019.6074/2018
Linitis plastica of the colon due to metastases of invasive lobular breast carcinoma
DOI: 10.17235/reed.2019.6065/2018
The first reported case of colonic infection caused by Candida glabrata
DOI: 10.17235/reed.2019.6057/2018
The main determinants of disability in IBD and its relationship to optimism
DOI: 10.17235/reed.2019.6033/2018
Treat to target in inflammatory bowel disease: a survey of treatment strategies amongst Portuguese doctors
DOI: 10.17235/reed.2019.6029/2018
A rare lymphoproliferative disorder associated with immunomodulating therapy in Crohn’s disease
DOI: 10.17235/reed.2019.5990/2018
Colorectal penetration by two intrauterine devices
DOI: 10.17235/reed.2019.5974/2018
Mantle cell lymphoma of the cecum
DOI: 10.17235/reed.2019.5936/2018
A granular cell tumor: an unusual colon polyp
DOI: 10.17235/reed.2018.5918/2018
Serrated Lesions in patients with Inflammatory Bowel Disease.
DOI: 10.17235/reed.2019.5910/2018
Endoscopic full-thickness resection (EFTR) after neoadjuvant chemotherapy: is it feasible?
DOI: 10.17235/reed.2019.5905/2018
Relationship between the polyp detection rate and the post-colonoscopy colorectal cancer rate
DOI: 10.17235/reed.2019.5889/2018
Inguinal abscess as presentation of a right colon cancer. A systematic review
DOI: 10.17235/reed.2020.5887/2018
Severe hyponatremia secondary to preparation for colonoscopy with sodium picosulfate/magnesium citrate
DOI: 10.17235/reed.2018.5832/2018
Colorectal cancer screening and survival
DOI: 10.17235/reed.2018.5870/2018
The use of serum calprotectin as a biomarker for inflammatory activity in inflammatory bowel disease
DOI: 10.17235/reed.2019.5797/2018
Prognostic differences between lymphoepithelioma-like colon carcinoma and colon adenocarcinoma
DOI: 10.17235/reed.2018.5765/2018
Effect of conscious sedation with midazolam and fentanyl on the overall quality of colonoscopy: a prospective and randomized study
DOI: 10.17235/reed.2019.5735/2018
Splenic rupture: an infrequent but potentially severe complication after colonoscopy
DOI: 10.17235/reed.2018.5719/2018
Vitamin D deficiency in outpatients with inflammatory bowel disease: prevalence and association with clinical-biological activity
DOI: 10.17235/reed.2018.5714/2018
Factors that predict the presence of non-small bowel lesions during capsule endoscopy examinations
DOI: 10.17235/reed.2018.5666/2018
Bacterial endogenous endophthalmitis after colonoscopy
DOI: 10.17235/reed.2018.5658/2018
Validation of a population pharmacokinetic model of adalimumab in a cohort of patients with inflammatory bowel disease
DOI: 10.17235/reed.2019.5600/2018
The association between de novo inflammatory bowel disease and celiac disease
DOI: 10.17235/reed.2019.5535/2018
Routine lower gastrointestinal endoscopy for radiographically confirmed acute diverticulitis. In whom and when is it indicated?
DOI: 10.17235/reed.2018.5524/2018
Letter to the Editor
Focal Pneumatosis cystoides intestinalis: optic colonoscopy and virtual colonoscopy features
DOI: 10.17235/reed.2018.5522/2018
Screening-detected colorectal cancers show better long-term survival compared with stage-matched symptomatic cancers
DOI: 10.17235/reed.2018.5509/2018
The right colon challenge
DOI: 10.17235/reed.2018.5544/2018
Online social networks and inflammatory bowel disease
DOI: 10.17235/reed.2018.5496/2018
A meta-analysis of dietary carbohydrate intake and inflammatory bowel disease risk: evidence from 15 epidemiology studies
DOI: 10.17235/reed.2018.5490/2018
Update of the SEPD position statement on the use of biosimilars for inflammatory bowel disease
DOI: 10.17235/reed.2018.5456/2018
Colon lymphomas: an analysis of our experience over the last 23 years
DOI: 10.17235/reed.2018.5445/2017
Quality indicators in colonoscopy. The colonoscopy procedure
DOI: 10.17235/reed.2018.5408/2017
A rare complication after colonoscopy: a splenic rupture
DOI: 10.17235/reed.2018.5362/2017
Switching from reference infliximab to CT-P13 in patients with inflammatory bowel disease: results of a multicenter study after 12 months
DOI: 10.17235/reed.2018.5368/2017
Managing iron deficiency and iron deficiency anemia in inflammatory bowel disease. The results of the “Gestiona hierro-EII” survey
DOI: 10.17235/reed.2018.5354/2017
Acute appendicitis after a colonic endoscopic submucosal resection
DOI: 10.17235/reed.2018.5307/2017
Prospective study of the factors associated with poor tolerance to ambulatory colonoscopy under conscious sedation
DOI: 10.17235/reed.2018.5287/2017
Contribution of the virtual colonoscopy in a case of intestinal intussusception
DOI: 10.17235/reed.2017.5261/2017
Idiopathic portal hypertension with regard to thiopurine treatment
DOI: 10.17235/reed.2018.5256/2017
Chemoprevention of polyp recurrence with curcumin followed by silibinin in a case of multiple colorectal adenomas
DOI: 10.17235/reed.2017.5178/2017
Short-term outcome of patients with colon cancer diagnosed by symptoms and screening
DOI: 10.17235/reed.2017.5158/2017
Nutritional deficiency during colonoscopy preparation: the forgotten iatrogeny
DOI: 10.17235/reed.2018.5140/2017
Assessing medication adherence in inflammatory bowel diseases. A comparison between a self-administered scale and a pharmacy refill index
DOI: 10.17235/reed.2017.5137/2017
The complexity of evaluating and increasing adherence in inflammatory bowel disease
DOI: 10.17235/reed.2017.5143/2017
Serrated polyposis syndrome associated with long-standing inflammatory bowel disease
DOI: 10.17235/reed.2017.5068/2017
Right-colon mucinous adenocarcinoma mimicking a hydatid cyst
DOI: 10.17235/reed.2017.5041/2017
Clinico-pathological and oncological differences between right and left-sided colon cancer (stages I-III): analysis of 950 cases
DOI: 10.17235/reed.2017.5034/2017
A bull horn fragment found on colonoscopy
DOI: 10.17235/reed.2017.5020/2017
Colonic diverticulosis and the metabolic syndrome: an association?
DOI: 10.17235/reed.2017.5009/2017
Fecal transplantation as a treatment for Clostridium difficile infection in patients with ulcerative colitis
DOI: 10.17235/reed.2017.4941/2017
Segmental intestinal necrosis in a young patient
DOI: 10.17235/reed.2017.4880/2017
Is capsule colonoscopy the solution for incomplete conventional colonoscopy?
DOI: 10.17235/reed.2017.5018/2017
Prevalence, risk factors and response to treatment of extra-intestinal manifestations in patients with inflammatory bowel disease
DOI: 10.17235/reed.2017.4845/2017
Colonic diverticular bleeding. Have we identified the risk factors for massive bleeding yet?
DOI: 10.17235/reed.2017.4821/2017
Fecal microbiota transplantation in recurrent Clostridium difficile infection in a patient with concomitant inflammatory bowel disease
DOI: 10.17235/reed.2017.4819/2016
Complete tubular colonic duplication in an adult: a rare incidental finding and the risk of colonoscopic perforation
DOI: 10.17235/reed.2017.4784/2016
Issue pending: minimizing anxiety before colonoscopy
DOI: 10.17235/reed.2016.4756/2016
Clinical-endoscopic relevance of incidental colorectal lesions detected by PET-CT
DOI: 10.17235/reed.2018.4719/2016
Epidemiology of inflammatory bowel disease in Málaga: incidence rate and follow-up of a cohort diagnosed between 2007-2008
DOI: 10.17235/reed.2017.4708/2016
A survey-based analysis on endoscopic quality indicators compliance among Spanish endoscopists
DOI: 10.17235/reed.2016.4705/2016
Specialist care in the management of inflammatory bowel disease
DOI: 10.17235/reed.2016.4628/2016
Colonic lesions in patients undergoing small bowel capsule endoscopy: incidence, diagnostic and therapeutic impact
DOI: 10.17235/reed.2017.4604/2016
Invasive pulmonary aspergillosis in an immunocompromised patient with severe ulcerative colitis
DOI: 10.17235/reed.2017.4564/2016
Intrauterine device in the rectal cavity
The use of a segmental endoscopic score may improve the prediction of clinical outcomes in acute severe ulcerative colitis
DOI: 10.17235/reed.2016.4470/2016
Primary chancre in the rectum: an underdiagnosed cause of rectal ulcer
DOI: 10.17235/reed.2017.4457/2016
3D echoendoscopy and miniprobes for rectal cancer staging
DOI: 10.17235/reed.2018.4453/2016
Previous exposure to biologics and C-reactive protein are associated with the response to tacrolimus in inflammatory bowel disease
DOI: 10.17235/reed.2016.4447/2016
Risk factors for tuberculosis in inflammatory bowel disease: anti-tumor necrosis factor and hospitalization
DOI: 10.17235/reed.2016.4440/2016
How is inflammatory bowel disease managed in Spanish gastroenterology departments? The results of the GESTIONA-EII survey
DOI: 10.17235/reed.2016.4410/2016
Colonic obstruction secondary to Actinomyces
DOI: 10.17235/reed.2017.4396/2016
Therapeutic impact of colon capsule endoscopy with PillCam™ COLON 2 after incomplete standard colonoscopy: a Spanish multicenter study
DOI: 10.17235/reed.2017.4369/2016
Colonic endoscopic full-thickness resection (EFTR) with the over-the-scope device (FTRD): a short case series
DOI: 10.17235/reed.2017.4259/2016
Colonic obstruction secondary to sigmoid fecaloma endoscopically resolved with Coca-Cola®
DOI: 10.17235/reed.2017.4209/2016
Acute colonic complications in a patient with Chagas disease
DOI: 10.17235/reed.2016.4193/2016
Pharmaceutical costs for inflammatory bowel disease units — An issue for department heads? The GESTIONAEII survey
DOI: 10.17235/reed.2016.4192/2016
Pneumatosis cystoides intestinalis
Risk factors for severity and recurrence of colonic diverticular bleeding
DOI: 10.17235/reed.2016.4190/2015
Endoscopic resection of colorectal polyps in patients on antiplatelet therapy: an evidence-based guidance for clinicians
DOI: 10.17235/reed.2016.4114/2015
Prospective study of anxiety in patients undergoing an outpatient colonoscopy
DOI: 10.17235/reed.2016.4104/2015
Association between the location of colon polyps at baseline and surveillance colonoscopy - A retrospective study
DOI: 10.17235/reed.2016.4095/2015
Serrated lesions and serrated polyposis syndrome
DOI: 10.17235/reed.2017.4065/2015
Colonic leishmaniasis in a patient with HIV: a case report
DOI: 10.17235/reed.2016.4038/2015
Acute transverse colon volvulus with secondary gastric isquemia. Case report
DOI: 10.17235/reed.2016.4024/2015
Enhanced flat adenoma detection rate with high definition colonoscopy plus i-scan for average-risk colorectal cancer screening
DOI: 10.17235/reed.2016.4008/2015
Idiopathic portal hypertension regarding thiopurine treatment in patients with inflammatory bowel disease
DOI: 10.17235/reed.2015.3954/2015
Contribution of infliximab population pharmacokinetic model for dose optimization in ulcerative colitis patients
DOI: 10.17235/reed.2015.3978/2015
Intussusception as clinical presentation of primary non-Hodgkin lymphoma of the colon in a HIV-patient
DOI: 10.17235/reed.2016.3965/2015
Immmunodeficiencies and autoimmune diseases: common variable immunodeficiency and Crohn-like
DOI: 10.17235/reed.2015.3872/2015
Hirschsprung disease with debut in adult age as acute intestinal obstruction: case report
DOI: 10.17235/reed.2016.3841/2015
Role of colonic microbiota in colorectal carcinogenesis: A systematic review
DOI: 10.17235/reed.2015.3830/2015
Endoscopic resection of rectal granular-cell tumor using elastic band ligation
DOI: 10.17235/reed.2016.3823/2015
Primary liposarcoma of the sigmoid presenting as colonic intussusception - A case report
DOI: 10.17235/reed.2016.3943/2015
Granular cell tumor of cecum
Endoscopic diagnosis of asymptomatic perforation of colonic diverticulum
Splenic rupture after colorectal cancer screening
DOI: 10.17235/reed.2015.3714/2015
Leiomyosarcoma of the ascending colon: a rare tumor with poor prognosis
DOI: 10.17235/reed.2015.3606/2014
Download the citation for this article by clicking on one of the following citation managers:
Received: 08/11/2019
Accepted: 20/11/2019
Online First: 24/06/2020
Published: 08/07/2020
Article Online First time: 229 days
Article editing time: 243 days
Submission and tracking
Access to the information published on the website (www.reed.es) of the Sociedad Española de Patología Digestiva (SEPD), Calle Sancho Dávila, 6, 28028 Madrid, CIF: G28486280, telephone: 914021353, e-mail: sepd@sepd.es, implies acceptance of the following conditions of use:
1. The SEPD published its website in order to make it easier for potential visitors to access information related to its services. The information displayed on this website is made available to users accessing the website, both privately and individually, at no additional cost. The commercialization of access rights is expressly prohibited.
2. It is expressly forbidden to copy or reproduce the information published by means of any electronic medium (web pages, databases, web pages or electronic publications) that allows the dissemination of any information published on this website to multiple users without the prior written consent of the SEPD.
3. Accuracy of information: The SEPD endeavors to display accurate and up-to-date information on its website. However, the SEPD is not responsible for the consequences of reading this information.
4. SEPD is not liable for any damages that the user may cause in connection with access to this website or the use of its contents.
5. Notice to users and/or patients: The information included in www.reed.es is for the exclusive use of healthcare professionals and this will be stated in the registration and access alert.
6. Funding: REED, the official scientific body of the EDPS, shares the same sources of funding as the EDPS, as laid down in Article 22, SECTION VII (ECONOMIC AND DOCUMENTARY SYSTEM) of the EDPS's Statutes.
The website http://www.reed.es may host advertising from third parties that may be considered of interest to the user and in no way a source of budgetary funding for the website. Wherever the word 'Advertising' is displayed, it will be highlighted.
However, advertising that infringes Law 29/2006 on guarantees and rational use of medicines and health products will not be accepted. Likewise, there will be no advertising of any kind in those areas of the website where there may be a conflict of interest.
Advertisers have no rights over their editorial content.
7. Access to restricted areas: In relation to access to restricted areas where the user voluntarily completes the registration form, the EDPS will assign the user a password which will be sent to the e-mail address provided by the user, who must make diligent use of the password and keep it secret. Consequently, the user accepts that he/she is responsible for the correct custody and confidentiality of the password/identifier provided by the EDPS. Furthermore, the user shall not provide access to third parties, either temporarily or permanently, or allow access to third parties.
Consequently, the user is solely responsible for all accesses, contents and actions he/she carries out in connection with his/her user ID and access code, with full indemnity for the EDPS.
On this basis, the user is responsible for immediately informing the EDPS of any factors that allow the misuse of the IDs and/or passwords, such as theft, loss or unauthorized access, in order to cancel them immediately. Until such incidents are reported, SEPD will not be liable for any liability that may arise from the misuse of identifiers or passwords by unauthorized third parties.
The user understands and accepts that he/she is accessing a website with content intended exclusively for medical staff and acknowledges that he/she is a healthcare professional.
Notes of interest to members and visitors to the EDPS website: The data and information contained in all content on these websites are only guidance documents for members and are therefore not legally binding.
8. License for public use of the website: is governed by Spanish law, regardless of the country in which the user accesses the website. Any controversy that may arise in the interpretation of these rules of access will be resolved before the Spanish Courts and Tribunals.
Copyright and Creative Commons POR NC ND: The total or partial reproduction of texts and graphics by any means is prohibited without the express written authorization of the EDPS. To insert these texts, images or news items in the publication or dissemination in any medium of any kind accessible to third parties, the express written consent of the EDPS must be obtained.
The private use of the texts, news and data published on this website is strictly for personal purposes.
The General Data Protection Regulation (Regulation (EU) 2016/679) harmonizes Data Protection legislation across the European Union, increasing the protection of individuals and giving them greater control over their personal data.
At the Spanish Society of Digestive Pathology (SEPD), we have always been concerned about the protection of personal data. We have therefore updated our Privacy Policy in order to bring it into line with the new regulations and to inform you of the changes that affect your rights:
Responsible for the processing of your personal data: SOCIEDAD ESPAÑOLA DE PATOLOGÍA DIGESTIVA (SEPD), CIF: G28486280 and registered office at Calle Sancho Dávila 6, 28028 Madrid.
The data collected by the Sociedad Española de Patología Digestiva (SEPD) are obtained in different ways (website, e-mail, electronic forms or on paper) through its activity as a business association and service provider; these data will become part of an information file for which it is responsible.
Purpose of data collection:
Legitimacy of the processing:
Recipients of the data.
Data subjects:
Everyone can know whether or not the EDPS processes their personal data. They have the right to:
SEPD will cease to process the data, except for legitimate reasons, or for the exercise or defense of possible claims.
Origin of the data: SEPD will obtain personal data directly from the data subject through the following communication channels:
Categories of data:
Sending of commercial communications: In accordance with the LSSI, Law 34/2002, and Law 29/2009, of 30 December, if you do not wish to receive any more commercial communications, please send an e-mail with the word BAJA (unsubscribe) to the following address: sepd@sepd.es.
Security measures: SEPD informs that it has adopted all necessary security measures to prevent theft, alteration or unauthorized access to data, taking into account the state of the art, the costs of implementation, the nature, scope, context and purpose of the processing, as well as the variable risks of probability and severity to the rights and freedoms of individuals, such as in cases of outsourced services, request and ensure that the controller implements appropriate technical and organizational measures to ensure an adequate level of security against existing threats, as stated in art. 32 of the Data Protection Regulation.
Exercise of rights:
Everyone has the right to know whether the EDPS processes his or her personal data. He or she also has the right to:
Access their personal data,
Request the rectification of inaccurate data.
Request deletion when, among other reasons, the data are no longer necessary for the purposes for which they were collected.
Object to the processing of your data, on grounds relating to your particular situation, by requesting that they not be processed by the EDPS.
In certain circumstances, request the restriction of the processing of your data, in which case they will only be kept for the exercise or defense of claims.
Withdraw, at any time, the consent given, without this affecting the lawfulness of the processing that we have carried out prior to such withdrawal.
The interested party may exercise their rights at the following address: Sociedad Española de Patología Digestiva (SEPD), c/ Calle Sancho Dávila, 6 28028 Madrid, or by email to the following address: sepd@sepd.es, any controversy that may arise in the interpretation of these access rules will be resolved before the Spanish Courts and Tribunals.
Remember that whenever you exercise any of the rights set out above, you must accompany your request with a copy of your ID card or equivalent document that allows us to verify your identity.
Likewise, if you are not satisfied with how we have dealt with your rights, you may file a complaint with the Spanish Data Protection Agency, through the website www.aepd.es.
The following table describes in detail the cookies present on the website
The user has also been informed of the cookies used by this website by means of the banner that appears on the home screen during the first browsing visit to this website, in which the user can configure them at their own discretion, requesting their consent and management.
A cookie is a small piece of information, usually a few kilobytes to several megabytes in size, which is stored on your terminal when you visit our website. The cookie is used to remember your preferences and other information about your browsing history of our website.
Cookies can be first-party or third-party cookies. This varies depending on whether the cookies are sent to your terminal from a computer or domain managed by us (own cookies), or are sent from a computer or domain not managed by us (third party cookies). They can remain active from a few minutes to several years, or only during the session.
Cookies can have many purposes and sometimes several are grouped together. In addition, there is a group of technical cookies that are necessary for the proper functioning of website, being mandatory to obtain consent for the rest of the cookies with different purposes. Depending on their purpose we can distinguish,
If you wish, you can also manage cookies through your browser. Most browsers are set by default to accept cookies, but you can change the settings to block, delete and manage some or all cookies if you prefer. Please be aware of the possible changes that can occur when deleting or blocking cookies.
Chrome:
https://support.google.com/chrome/answer/95647?hl=es
Explorer:
https://support.microsoft.com/es-es/topic/eliminar-y-administrar-cookies-168dab11-0753-043d-7c16-ede5947fc64d
Edge:
https://support.microsoft.com/es-es/microsoft-edge/eliminar-las-cookies-en-microsoft-edge-63947406-40ac-c3b8-57b9-2a946a29ae09
Safari:
- Ipad, Iphone, Ipod Touch: https://support.apple.com/es-es/HT201265
- Mac: Preferencias, Panel de privacidad
Firefox:
https://support.mozilla.org/es/kb/Borrar%20cookies